Home administration of misoprostol for early medical abortion in India

International Journal of Gynecology and Obstetrics

Volumn 108, Issue 3, 2010, Pages 228-232

  Bracken, Hillary ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

Author keywords

Home administration; India; Medical abortion; Mifepristone; Misoprostol

Indexed keywords

CODEINE; MIFEPRISTONE; MISOPROSTOL; PARACETAMOL;

ADULT; AMENORRHEA; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFICACY; FAMILY PLANNING; FEMALE; HOME CARE; HUMAN; INDIA; INFORMED CONSENT; MAJOR CLINICAL STUDY; MEDICAL ABORTION; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 76049086575     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.09.027     Document Type: Article

References (20)

1. Mundle S., Elul B., Anand A., Kalyanwala S., and Ughade S. Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center. Contraception 76 1 (2007) 66-70
2. Mundle S., Kalyanwala S., Elul B., and Ughade S. Simplifying medical abortion: home administration of misoprostol. J Obstet Gynecol India 58 5 (2008) 410-416
3. Coyaji K., Elul B., Krishna U., Otiv S., Ambardekar S., Bopardikar A., et al. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception 66 1 (2002) 33-40
4. Coyaji K., Krishna U., Ambardekar S., Bracken H., Raote V., and Mandlekar A. Are two doses of misoprostol after mifepristone for early abortion better than one?. BJOG 114 3 (2007) 271-278
5. Desai S, Alidac Z. Abortion is About Autonomy. Autonomy is a Core Value. Presentation given at "Medical Abortion in South Asia: What is new? What is next?" held on 23-24 October 2008 at The Hyatt Regency in Kathmandu, Nepal.
6. Creanga A.A., Roy P., and Tsui A.O. Characteristics of abortion service providers in two northern Indian states. Contraception 78 6 (2008) 500-506
7. Ramachandar L., and Pelto P.J. Medical abortion in rural Tamil Nadu, South India: a quiet transformation. Reprod Health Matters 13 26 (2005) 54-64
8. Ganatra B., Manning V., and Pallipamulla S.P. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India. Reprod Health Matters 13 26 (2005) 65-74
9. Schaff E.A., Stadalius L.S., Eisinger S.H., and Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 44 4 (1997) 353-360
10. Schaff E.A., Fielding S.L., Westhoff C., Ellertson C., Eisinger S.H., Stadalius, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. JAMA 284 15 (2000) 1948-1953
11. Schaff E.A., Fielding S.L., Eisinger S.H., Stadalius L.S., and Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 61 1 (2000) 41-46
12. Elul B., Hajri S., Ngoc N.N., Ellertson C., Slama C.B., Pearlman E., et al. Can women in less-developed countries use a simplified medical abortion regimen?. Lancet 357 9266 (2001) 1402-1405
13. Karki C., Pokharel H., Kushwaha A., Manandhar D., Bracken H., and Winikoff B. Acceptability and feasibility of medical abortion in Nepal. Int J Gynecol Obstet 106 1 (2009) 39-42
14. Ngoc N.T., Nhan V.Q., Blum J., Mai T.T., Durocher J.M., and Winikoff B. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. BJOG 111 8 (2004) 814-819
15. International Planned Parenthood. First Trimester Abortion Guidelines and Protocols (2008), International Planned Parenthood Federation, London. http://www.ippf.org/NR/rdonlyres/D84AFDB1-B6CC-4899-8E3C-5D3392A85F8F/0/abortion_protocol.pdf Available at: http://www.ippf.org/NR/rdonlyres/D84AFDB1-B6CC-4899-8E3C-5D3392A85F8F/0/abortion_protocol.pdf. Accessed May 3, 2009
16. National Abortion Federation. National Abortion Federation (NAF) protocol for mifepristone-misoprostol in early abortion. Available at: http://www.prochoice.org/pubs_research/publications/downloads/professional_education/medical_abortion/protocol_mife_miso.pdf. Accessed June 12, 2009.
17. Hedley A., Trussell J., Turner A.N., Coyaji K., Ngoc N.T., Winikoff B., et al. Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion. Contraception 69 2 (2004) 157-163
18. Suhonen S., Heikinheimo O., Tikka M., and Haukkamaa M. The learning curve is rapid in medical termination of pregnancy-first-year results from the Helsinki area. Contraception 67 3 (2003) 223-227
19. Vitner D., Machtinger R., Baum M., Goldenberg M., Schiff E., and Seidman D. High failure rates of medical termination of pregnancy after introduction to a large teaching hospital. Fertil Steril 91 Suppl 4 (2009) 1374-1377
20. Akin A., Blum J., Ozalp S., Onderoglu L., Kirca U., Bilgili, et al. Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception 70 5 (2004) 401-406